Logo image of XPOF

XPONENTIAL FITNESS INC-A (XPOF) Stock Fundamental Analysis

NYSE:XPOF - New York Stock Exchange, Inc. - US98422X1019 - Common Stock - Currency: USD

9.08  -0.27 (-2.89%)

Premarket: 9.08 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XPOF. XPOF was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. XPOF is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year XPOF has reported negative net income.
In the past year XPOF had a positive cash flow from operations.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.
XPOF Yearly Net Income VS EBIT VS OCF VS FCFXPOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

XPOF's Return On Assets of -16.15% is on the low side compared to the rest of the industry. XPOF is outperformed by 91.73% of its industry peers.
XPOF's Return On Invested Capital of 14.51% is amongst the best of the industry. XPOF outperforms 81.95% of its industry peers.
XPOF had an Average Return On Invested Capital over the past 3 years of 10.38%. This is below the industry average of 13.97%.
The 3 year average ROIC (10.38%) for XPOF is below the current ROIC(14.51%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -16.15%
ROE N/A
ROIC 14.51%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
XPOF Yearly ROA, ROE, ROICXPOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

XPOF has a Operating Margin of 16.74%. This is in the better half of the industry: XPOF outperforms 72.18% of its industry peers.
XPOF has a Gross Margin of 75.50%. This is amongst the best in the industry. XPOF outperforms 91.73% of its industry peers.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 16.74%
PM (TTM) N/A
GM 75.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
XPOF Yearly Profit, Operating, Gross MarginsXPOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), XPOF is creating some value.
The number of shares outstanding for XPOF has been increased compared to 1 year ago.
The number of shares outstanding for XPOF has been increased compared to 5 years ago.
The debt/assets ratio for XPOF is higher compared to a year ago.
XPOF Yearly Shares OutstandingXPOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPOF Yearly Total Debt VS Total AssetsXPOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

XPOF has an Altman-Z score of -0.75. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XPOF (-0.75) is worse than 90.23% of its industry peers.
XPOF has a debt to FCF ratio of 41.09. This is a negative value and a sign of low solvency as XPOF would need 41.09 years to pay back of all of its debts.
The Debt to FCF ratio of XPOF (41.09) is worse than 60.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 41.09
Altman-Z -0.75
ROIC/WACC1.32
WACC11.01%
XPOF Yearly LT Debt VS Equity VS FCFXPOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

2.3 Liquidity

XPOF has a Current Ratio of 0.81. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.81, XPOF is in line with its industry, outperforming 42.86% of the companies in the same industry.
XPOF has a Quick Ratio of 0.81. This is a bad value and indicates that XPOF is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.75, XPOF perfoms like the industry average, outperforming 45.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.75
XPOF Yearly Current Assets VS Current LiabilitesXPOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for XPOF have decreased strongly by -209.52% in the last year.
XPOF shows a decrease in Revenue. In the last year, the revenue decreased by -2.99%.
XPOF shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.93% yearly.
EPS 1Y (TTM)-209.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-3.32%

3.2 Future

Based on estimates for the next years, XPOF will show a very strong growth in Earnings Per Share. The EPS will grow by 211.07% on average per year.
The Revenue is expected to grow by 5.42% on average over the next years.
EPS Next Y857.35%
EPS Next 2Y315.39%
EPS Next 3Y211.07%
EPS Next 5YN/A
Revenue Next Year0.45%
Revenue Next 2Y3.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPOF Yearly Revenue VS EstimatesXPOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
XPOF Yearly EPS VS EstimatesXPOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

XPOF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 5.95 indicates a rather cheap valuation of XPOF.
Based on the Price/Forward Earnings ratio, XPOF is valued cheaper than 96.99% of the companies in the same industry.
XPOF's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.39.
Industry RankSector Rank
PE N/A
Fwd PE 5.95
XPOF Price Earnings VS Forward Price EarningsXPOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

XPOF's Enterprise Value to EBITDA ratio is in line with the industry average.
XPOF's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 50.37
EV/EBITDA 11.18
XPOF Per share dataXPOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 -6

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 211.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y315.39%
EPS Next 3Y211.07%

More info and screens

0

5. Dividend

5.1 Amount

XPOF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPONENTIAL FITNESS INC-A

NYSE:XPOF (6/10/2025, 8:17:57 PM)

Premarket: 9.08 0 (0%)

9.08

-0.27 (-2.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners80.89%
Inst Owner Change4.33%
Ins Owners4.3%
Ins Owner Change0.45%
Market Cap441.83M
Analysts80
Price Target14.05 (54.74%)
Short Float %12.35%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP-8.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-183.83%
Min EPS beat(2)-219.74%
Max EPS beat(2)-147.92%
EPS beat(4)0
Avg EPS beat(4)-148.82%
Min EPS beat(4)-219.74%
Max EPS beat(4)-112.98%
EPS beat(8)0
Avg EPS beat(8)-93.76%
EPS beat(12)0
Avg EPS beat(12)-181.84%
EPS beat(16)0
Avg EPS beat(16)-172.7%
Revenue beat(2)2
Avg Revenue beat(2)0.29%
Min Revenue beat(2)0.01%
Max Revenue beat(2)0.58%
Revenue beat(4)3
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)3.21%
Revenue beat(8)6
Avg Revenue beat(8)1.44%
Revenue beat(12)10
Avg Revenue beat(12)4.31%
Revenue beat(16)14
Avg Revenue beat(16)6.08%
PT rev (1m)-3.65%
PT rev (3m)-28.8%
EPS NQ rev (1m)-12.4%
EPS NQ rev (3m)-43.66%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-51.27%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-6.15%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-6.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.95
P/S 1.39
P/FCF 50.37
P/OCF 29.85
P/B N/A
P/tB N/A
EV/EBITDA 11.18
EPS(TTM)-0.46
EYN/A
EPS(NY)1.53
Fwd EY16.8%
FCF(TTM)0.18
FCFY1.99%
OCF(TTM)0.3
OCFY3.35%
SpS6.53
BVpS-2.23
TBVpS-7.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.15%
ROE N/A
ROCE 18.36%
ROIC 14.51%
ROICexc 15.98%
ROICexgc 148.18%
OM 16.74%
PM (TTM) N/A
GM 75.5%
FCFM 2.76%
ROA(3y)-5.36%
ROA(5y)-7.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.38%
ROIC(5y)N/A
ROICexc(3y)11.53%
ROICexc(5y)N/A
ROICexgc(3y)87.99%
ROICexgc(5y)N/A
ROCE(3y)13.14%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.58%
GM growth 5Y3.29%
F-Score3
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 41.09
Debt/EBITDA 5.07
Cap/Depr 37.13%
Cap/Sales 1.9%
Interest Coverage 1.29
Cash Conversion 21.32%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.75
Altman-Z -0.75
F-Score3
WACC11.01%
ROIC/WACC1.32
Cap/Depr(3y)65.89%
Cap/Depr(5y)60.54%
Cap/Sales(3y)3.86%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-225%
EPS Next Y857.35%
EPS Next 2Y315.39%
EPS Next 3Y211.07%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y27.35%
Revenue growth 5Y19.93%
Sales Q2Q%-3.32%
Revenue Next Year0.45%
Revenue Next 2Y3.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y-11.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year539.1%
EBIT Next 3Y103.17%
EBIT Next 5YN/A
FCF growth 1Y-79.84%
FCF growth 3Y-17.41%
FCF growth 5YN/A
OCF growth 1Y-75.39%
OCF growth 3Y-6.86%
OCF growth 5Y49.76%